Authors: Carling, RW Moore, KW Moyes, CR Jones, EA Bonner, K Emms, F Marwood, R Patel, S Patel, S Fletcher, AE Beer, M Sohal, B Pike, A Leeson, PD

Citation: Rw. Carling et al., 1-(3-cyanobenzylpiperidin-4-yl)-5-methyl-4-phenyl-1,3-dihydroimidazol-2-one: A selective high-affinity antagonist for the human dopamine D-4 receptorwith excellent selectivity over ion channels, J MED CHEM, 42(14), 1999, pp. 2706-2715

Authors: van Niel, MB Collins, I Beer, MS Broughton, HB Cheng, SKF Goodacre, SC Heald, A Locker, KL MacLeod, AM Morrison, D Moyes, CR O'Connor, D Pike, A Rowley, M Russell, MGN Moyes, CR O'Connor, D Pike, A Rowley, M Russell, MGN Sohal, B Stanton, JA Thomas, S Verrier, H Watt, AP Castro, JL

Citation: Mb. Van Niel et al., Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profiles, J MED CHEM, 42(12), 1999, pp. 2087-2104